Rate My Professor Manuel Espinoza

Espinoza specializes in health technology assessment and health economics, focusing on economic evaluation, priority setting in health, new methods for heterogeneity and equity in economic evaluation, and value frameworks for health decision-making. He has held major leadership positions such as Director of the Board of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), President of the ISPOR Latin America Consortium, co-editor of Value in Health, Editor-in-Chief of Value in Health Regional Issues, and Chair of the Latin America Policy Forum of Health Technology Assessment International (HTAi). Key publications include "Improving efficiency in healthcare: lessons from successful health policies in Chile" (Archives of Medical Research, 2025), "Good Practices for Health Technology Assessment Guideline Development" (Value in Health, 2025), "The Socioeconomic Distribution of Life Expectancy and Healthy Life Expectancy in Chile" (International Journal for Equity in Health, 2023), "Economic evaluation of a Multimorbidity patients centered care model implemented in the Chilean Public Health System" (BMC Health Services Research, 2023), "Health and economic effects on patients with Type 2 Diabetes Mellitus in the long run" (Diabetology & Metabolic Syndrome, 2022), "Social value and individual choice" (Health Economics, 2018), and "The value of heterogeneity for cost-effectiveness subgroup analysis" (Medical Decision Making, 2014). His contributions have influenced health policy and decision-making in multiple countries.